CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01355107
NCT01355107N/ACompleted

Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease - a Pilot Trial

University Hospital Freiburg·observational·Posted May 17, 2011·Updated Dec 14, 2011

In Brief

An observational study for Hepatitis C and 2 related conditions. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The incidence of hepatocellular carcinoma (HCC) is rising worldwide.One important etiology is a chronic inflammation due to hepatitis c (hcv) infection. Over the steps of a chronic inflammation over the stadium of cirrhosis of the liver it is possible that neoplastic nodules appear in the liver which can rise up to a HCC. In the pathogenesis of HCC oxidative stress seems to play an important role and as selenium is a key micronutrient in this process its levels could differ between the different stages of disease in hcv- infected patients. The aim of this trial is to examine these differences.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany
CollaboratorsBiosyn

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 17, 2011
Enrollment StartApr 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 15.1 years ago